合康新能(300048.SZ):擬轉讓合康動力60%股權及合康智能64%股權
格隆匯 2 月 9日丨合康新能(300048.SZ)公佈,2021年2月9日,公司與上海上豐集團有限公司(“上海上豐”)及葉進吾簽訂了《武漢合康動力技術有限公司股權轉讓及有關債務安排協議》、《武漢合康智能電氣有限公司股權轉讓及有關債務安排協議》,公司擬將控股子公司武漢合康動力技術有限公司(“合康動力”)60%股權以1元人民幣轉讓給公司股東上海上豐及葉進吾、擬將武漢合康智能電氣有限公司(“合康智能”)64%股權以3206萬元轉讓給公司股東上海上豐及葉進吾。上述交易完成後,合康動力、合康智能將不再是公司控股子公司,不再納入公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.